Last updated: February 14, 2025
Sponsor: Memorial Sloan Kettering Cancer Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Histiocytoma
Treatment
online surveys
Clinical Study ID
NCT03990428
19-213
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Self-identified informal caregiver (family member or friend who provides unpaidsupport) for a patient with Erdheim-Chester Disease (or LCH, RDD, or JXG for theexploratory aim).
Proficiency to complete study assessments in English, evaluated at the time ofconsent.
Age 18 or over.
Exclusion
Exclusion Criteria:
Participant unwilling to sign consent.
Participant unable to complete web-based assessments.
Study Design
Total Participants: 170
Treatment Group(s): 1
Primary Treatment: online surveys
Phase:
Study Start date:
June 14, 2019
Estimated Completion Date:
June 30, 2026
Connect with a study center
Memorial Sloan Kettering Cancer Center
New York, New York 10065
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.